Search
for
Sort by
Research 451–480 of 1000+
- Androgens and androgen receptor action in skin and hair follicles
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- The therapeutic use of androgens in women
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Novel agents for the treatment of alopecia
- The rationale for physiological testosterone replacement in women
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Graham Little-Piccardi-Lassueur syndrome associated with androgen insensitivity syndrome (testicular feminization)
- What is the Rationale for Androgen Therapy for Women?
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis
- Urinary steroids in women with androgenic alopecia
- Female Androgenic Alopecia
- Alopecia - the search for novel agents continues
- Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients
- “Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging
- A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells
- Markers of peripheral androgen action in vivo and in vitro
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Evaluation of ischemia-modified albumin level and parameters related with oxidative stress in early onset androgenetic alopecia
- Docosahexaenoic acid-acylated astaxanthin esters alleviate cisplatin- induced acute kidney injury by modulating the ferroptosis-related GPX4/xCT signaling pathway and reducing oxidative stress
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- THE GENETICS OF CYP GENE VARIANTS IN ASSOCIATION WITH POLYCYSTIC OVARY SYNDROME: A NARRATIVE REVIEW
- Challenges in diagnosing ovarian sertoli-leydig cell tumors: A Peruvian case series
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- FRI220 Primary Bilateral Macronodular Adrenal Hyperplasia: A Rare Cause Of Cushing Syndrome